Pieris Pharmaceuticals

-$0.01 (-0.30%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PIRS and other ETFs, options, and stocks.

About PIRS

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas.

CEO
Stephen S. Yoder
Employees
123
Headquarters
Boston, Massachusetts
Founded
2001

PIRS Key Statistics

Market Cap
212.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.00M
High Today
$3.40
Low Today
$3.21
Open Price
$3.35
Volume
735.53K
52 Week High
$5.09
52 Week Low
$1.70

PIRS Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure